Verrica Pharmaceuticals Inc.

NasdaqGM:VRCA 株式レポート

時価総額：US$45.1m

Verrica Pharmaceuticals マネジメント

マネジメント 基準チェック /24

Verrica Pharmaceuticalsの CEO はJayson Riegerで、 Nov2024年に任命され、 の在任期間は 8.92年です。 は、会社の株式の1.23%を直接所有しており、その価値は$ 553.39K 。経営陣と取締役会の平均在任期間はそれぞれ4.3年と7.7年です。

主要情報

Jayson Rieger

最高経営責任者

n/a

報酬総額

CEO給与比率n/a
CEO在任期間no data
CEOの所有権1.2%
経営陣の平均在職期間4.3yrs
取締役会の平均在任期間7.7yrs

経営陣の近況

Recent updates

The Price Is Right For Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Even After Diving 49%

Oct 03
The Price Is Right For Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Even After Diving 49%

Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Analysts Are Cutting Their Estimates: Here's What You Need To Know

Aug 17
Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Analysts Are Cutting Their Estimates: Here's What You Need To Know

With A 67% Price Drop For Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) You'll Still Get What You Pay For

Aug 16
With A 67% Price Drop For Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) You'll Still Get What You Pay For

Is Verrica Pharmaceuticals (NASDAQ:VRCA) Using Debt In A Risky Way?

Jul 21
Is Verrica Pharmaceuticals (NASDAQ:VRCA) Using Debt In A Risky Way?

Is Verrica Pharmaceuticals (NASDAQ:VRCA) Using Debt In A Risky Way?

Jan 11
Is Verrica Pharmaceuticals (NASDAQ:VRCA) Using Debt In A Risky Way?

Here's Why We're Not At All Concerned With Verrica Pharmaceuticals' (NASDAQ:VRCA) Cash Burn Situation

Jun 28
Here's Why We're Not At All Concerned With Verrica Pharmaceuticals' (NASDAQ:VRCA) Cash Burn Situation

We're Hopeful That Verrica Pharmaceuticals (NASDAQ:VRCA) Will Use Its Cash Wisely

Feb 05
We're Hopeful That Verrica Pharmaceuticals (NASDAQ:VRCA) Will Use Its Cash Wisely

Vectoring Back In On Verrica Pharmaceuticals

Aug 31

Verrica Pharmaceuticals reports insider buying

Jul 06

Verrica Pharmaceuticals stock slides on proposed share offering

Jun 29

Verrica Pharmaceuticals Should Receive Second CRL Today

May 24

CEO（最高経営責任者

Jayson Rieger (48 yo)

no data

在職期間

Dr. Jayson M. Rieger, Ph D., M.B.A., is President, CEO & Director of Verrica Pharmaceuticals Inc. from November 5, 2024. Dr. Rieger serves as Non-Executive Independent Director at Lytix Biopharma AS since...

リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Christopher Hayes
Chief Legal Officer6.2yrsUS$2.56m0.14%
$ 65.1k
Jayson Rieger
Presidentno dataデータなし1.23%
$ 553.4k
John Kirby
Interim CFOno dataデータなしデータなし
Gary Goldenberg
Chief Medical Officer4.3yrsUS$989.18k0.12%
$ 53.7k
Eugene Scavola
Executive Vice President of Technical Operations5.1yrsデータなしデータなし
Bradley Catalone
Head of Drug Development4.3yrsデータなしデータなし

4.3yrs

平均在職期間

50yo

平均年齢

経験豊富な経営陣: VRCAの経営陣は 経験豊富 であると考えられます ( 4.3年の平均在職年数)。

取締役

名称ポジション在職期間報酬所有権
Jayson Rieger
President8.9yrsデータなし1.23%
$ 553.4k
Mark Prygocki
Independent Director6.5yrsUS$119.19k0%
$ 0
Mark Lebwohl
Member of Scientific Advisory Boardno dataデータなしデータなし
Lawrence F. Eichenfield
Independent Director4.3yrsUS$119.19k0%
$ 0
Sean Stalfort
Director8.9yrsデータなし1.01%
$ 457.5k
Paul Manning
Chairman of the Board8.9yrsデータなし29.71%
$ 13.4m
Ted White
Director6.5yrsUS$3.50m0.23%
$ 102.4k
Steven Cohen
Member of Scientific Advisory Boardno dataデータなしデータなし
Elaine Siegfried
Member of Scientific Advisory Boardno dataデータなしデータなし
Anthony Mancini
Member of Scientific Advisory Boardno dataデータなしデータなし
Janice Pelletier
Member of Scientific Advisory Boardno dataデータなしデータなし
Robert Greenberg
Member of Scientific Advisory Boardno dataデータなしデータなし

7.7yrs

平均在職期間

58yo

平均年齢

経験豊富なボード: VRCAの 取締役会 は 経験豊富 であると考えられます ( 7.7年の平均在任期間)。